Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Haemonetics Corp.

Headquarters: Boston, MA, United States of America
Year Founded: 1971
Status: Public
Industry Sector: HealthTechnology
CEO: Christopher A. Simon, MBA
Number Of Employees: 3,657
Enterprise Value: $5,081,817,950
PE Ratio: 25.95
Exchange/Ticker 1: NYSE:HAE
Exchange/Ticker 2: N/A
Latest Market Cap: $3,312,158,464

BioCentury | Nov 10, 2021
Management Tracks

Wandeler to leave MorphoSys

Plus: Rubius, AstraZeneca, Landos, Nyxoah, Progenity and more
BioCentury | May 6, 2013
Company News

Haemonetics, Hemerus Medical deal

BioCentury | May 7, 2012
Company News

Haemonetics, Hemerus Medical, Pall deal

BioCentury | Dec 20, 2004
Company News

SeraCare management update

BioCentury | Nov 15, 2004
Company News

Arryx Inc., Haemonetics Corp. deal

BioCentury | Aug 25, 2003
Company News

Haemonetics Corp. management update

BioCentury | Jun 25, 2001
Company News

Select Therap, Haemonetics Corp. deal

BioCentury | Jan 31, 2000
Company News

V.I. Technologies, Haemonetics Corp. deal

BioCentury | May 18, 1998
Company News

OraVax management update

Items per page:
1 - 10 of 11